Notice for ataluren (PTC Therapeutics Australia Pty Ltd)
Active ingredients
ataluren
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
granules for oral suspension
Indication
For the treatment of patients with Duchenne muscular dystrophy
Therapeutic area
Musculoskeletal